Skip to main content

Table 3 Patient wise number of cases who scored differently later by at least one grade of RNFS score at baseline

From: Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy

patient code Number of affected parameters at BL (<BPG) Alteration in score by at least one grade
No change; n (%) Better; n (%)
80488 22 2 (9.1) 20 (90.9)
80499 12 3 (25.0) 9 (75.0)
80680 11 0 11 (100.0)
80710 15 3 (20.0) 12(80.0)
80723 12 3 (25.0) 9 (75.0)
80806 2 1 (50.0) 1 (50.0)
80926 4 2 (50.0) 2 (50.0)
81128 10 4 (40.0) 6 (60.0)
80562 17 0 17 (100.0)
80568 17 4 (23.5) 13 (76.5)
80626 14 4 (28.6) 10 (71.4)
80637 15 9 (60.0) 6 (40.0)
80673 10 5 (50.0) 5 (50.0)
80768 13 7 (53.8) 6 (46.2)
80889 8 3 (37.5) 5 (62.5)
80981 5 0 5 (100.0)
81105 12 6 (50.0) 6 (50.0)
81114 6 5 (83.3) 1 (16.7)
81180 17 10 (58.8) 7 (41.2)
81187 7 4 (57.1) 3 (42.9)
81238 4 0 4 (100.0)
81249 9 6 (66.7) 3 (33.3)
81275 9 8 (88.9) 1 (11.1)
81296 8 6 (75.0) 2 (25.0)
  1. RNFS reverse nutech functional score; BL baseline; BPG best possible grade